Vacuum Blood Collection Systems Market size was valued at 1.87 billion in 2021 and is expected to reach 2.67 billion by 2028, at a CAGR of 5.2% during the forecast period 2022 to 2028.  Vacuum blood collection device is a closed system used to gather the blood test direct to the patient’s vein into the fitting test tube. As the name proposes the gadgets depends on vacuum innovation. The vacuum blood accumulation gadget avoids needle stick damage by dispensing with needles from human contact. The vacuum blood accumulation gadget maintains a strategic distance from the odds of the chancy shower of liquid getting into the air when the needle is withdrawn and furthermore dodges the potential aerosoling. Vacuum Blood Collection Systems market have plentiful of market players and it is consolidated. In terms of processing devices, strong market players are present. Companies in this market are focusing on new product develepments and market expansions for strengthen their market share. Furthermore companies are also stregnthening their posistion by acquiring the other companies operating in same market. For instance, in August 2012, Haemonetics Corporation acquired business assets of blood collection, filteration and processing product lines of Pall Corpration. On November 11, 2013, Grifols, a global healthcare company and producer of plasma therapies, acquired the transfusion diagnostics unit of Novartis. Furthermore, government organizations and non-government organizations are also playing major role in providing awareness regarding life threatening diseases, blood transfusion, blood donation etc. For example, in 2011, Government of South Africa and CDC entered into collaboration in order to develop national HIV research and clinical guidelines, conducting epidemiology training, and awareness programmes on TB and HIV.